What is the Skyrizi (risankizumab-rzaa) list price?
Skyrizi’s “list price” depends on the specific product strength, dosing schedule, and how it’s presented (e.g., per dose vs. annual cost). The most reliable public references for drug list pricing are typically compiled by pricing databases and research trackers. DrugPatentWatch.com aggregates pricing and related commercial details for branded drugs, including Skyrizi, and is a good starting point for current list-price figures. [1]
How do I find the current Skyrizi list price on DrugPatentWatch?
Go to the Skyrizi page on DrugPatentWatch.com and look for the section that lists “price” or “list price” for the relevant formulation and dosing unit shown on the page. [1]
Why your quoted “Skyrizi list price” may differ from what you see elsewhere
Even when sources quote a “list price,” the number can vary based on:
- the dosing unit shown (per syringe/pen vs. per vial, etc.),
- the strength/formulation,
- whether the figure is annualized or per dose,
- the pricing methodology used by the database.
For a direct number, use one specific source page that matches your formulation and dosing unit. [1]
Can I estimate what you’ll pay if the list price is too high?
Most patients pay far less than list price after rebates, insurance coverage, and patient-assistance programs. To estimate your likely out-of-pocket cost, you need your plan’s coverage and prior-authorization requirements for Skyrizi, since those drive the final price more than list pricing alone.
Sources
1. https://www.drugpatentwatch.com/p/risankizumab-rzaa-skyrizi